Article
Boston Scientific may be shielded from weight-loss drugs hit by procedure recovery
Rating:
0.0
Views:
60
Likes:
1
Library:
1
Boston Scientific's quarterly results on Thursday are likely to show the benefits of a rebound in elective procedures and help ease fears that the medical device maker could take a hit from the surging popularity of weight-loss drugs.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value